Back to Authors

Garcia, Christine

0000-0002-9728-3670

Mayo Clinic

Kaiser Permanente

Citations 2

Effectiveness of opportunistic bilateral salpingectomy in preventing epithelial ovarian cancer: a population-based study
Bahrami, Foruzan , McLeod, Julianne, Pearce, Celeste Leigh, Kushi, Lawrence H, Garcia, Christine, McAlpine, Jessica N, Gamez, Jamie N Bakkum, Tischer, Kristin M, Huntsman, David, Hanley, Gillian E, McAlpine, Jessica N. , Hanley, Gillian E. , Tischer, Kristin M. , Bakkum Gamez, Jamie N, McAlpine, Jessica N , Tischer, Kristin M. , Pearce, Celeste Leigh, Kushi, Lawrence H. , Garcia, Christine , Yong, Paul J. , Vera, Mary A. De , Gamez, Jamie N Bakkum

JNCI: Journal of the National Cancer Institute | July 24, 2026 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.1093/jnci/djag251 Get It

Abstract Background Opportunistic bilateral salpingectomy (OBS), the removal of fallopian tubes during hysterectomy or instead of tubal ligation, is recommended to reduce ovarian cancer risk. However, data on the effectiveness of prophylactic OBS is limited. Methods This population-based retrospective cohort included individuals aged 18–80 in Ontario, Canada, who underwent OBS or comparator surgeries (hysterectomy with ovarian and tubal conservation or tubal ligation) from 2011 to 2023. Individuals with gynecologic cancer before or within six months of surgery were excluded. Hazard ratios and 95% confidence intervals were estimated using Cox proportional hazards regression. Sensitivity analyses varied the time between surgery and cancer diagnosis to account for pre-existing serous tubal intraepithelial carcinomas. Results Among 196,839 individuals, 57,941 underwent OBS and 138,898 underwent comparator surgeries. 142 epithelial ovarian cancers were diagnosed (19 in the OBS group and 123 in the comparator surgery group). OBS was associated with reduced risk of any ovarian carcinoma, with an adjusted hazard ratio (aHR) of 0.60 (95% CI, 0.36 to 0.98). For serous ovarian carcinoma (high- and low-grade combined due to missing grade data), the aHR was 0.47 (95% CI, 0.22 to 0.99). Sensitivity analyses with 12- and 18-month intervals showed aHRs of 0.59 (95% CI, 0.35 to 0.99) and 0.60 (95% CI, 0.35 to 1.01) for all ovarian carcinomas, and 0.49 (95% CI, 0.23 to 1.01) and 0.47 (95% CI, 0.22 to 0.99) for serous ovarian carcinoma, respectively. Conclusions OBS was associated with reduced risk of ovarian carcinoma, supporting its role as a primary prevention strategy.
Serous Ovarian Cancer Following Opportunistic Bilateral Salpingectomy
Sowamber, Ramlogan , Mei, Alice J. , Kaur, Paramdeep, McLeod, Julianne, McKay, Emily , Lukey, Alex, Bakkum-Gamez, Jamie, Buza, Natalia, Cohen, Paul A., Farrell, Rhonda, Garcia, Christine, Gilks, Blake, Goode, Ellen, Howitt, Brooke, Hui, Pei, Köbel, Martin , Kushi, Lawrence, Kwon, Janice, Long-Roche, Kara C., Malpica, Anais, McAlpine, Jessica N., Miller, Dianne , Oliva, Esther, Paliga, Aleksandra, Parra-Herran, Carlos, Pearce, Celeste Leigh , Piek, Jurgen Martinus, Qiu, Haiyan, Rabban, Joseph T. , Rome, Robert, Steenbeek, Miranda, Stone, R., Talhouk, Aline , Tischer, Kristin M., Huntsman, David G., Howitt, Brooke E. , Cohen, Paul A. , Piek, Jurgen M.J. , Tischer, Kristin M. , Köbel, Martin , Cohen, Paul , Kaur, Paramdeep , Bakkum‐Gamez, Jamie N. , Buza, Natália , Devins, Kyle M. , Farrell, Rhonda , Garcia, Christine , Gilks, C. Blake , Goode, Ellen L. , Hodgson, Anjelica , Hui, Pei, Huvila, Jutta , Karnezis, Anthony N. , Keyhanian, Kianoosh , Kinloch, Mary A. , Kommoss, Felix , Kushi, Lawrence H. , Kwon, Janice S. , Malpica, Anais, McAlpine, Jessica N. , Oliva, Esther , Palicelli, Andrea , Parra‐Herran, Carlos , Perera, Sharnel , Steenbeek, Miranda, Tischer, Kristin M. , Trabert, Britton , Webb, Penelope M. , Zalcberg, John , Huntsman, David G. , Hanley, Gillian E.

JAMA Network Open | February 2, 2026 | Volume: 9 | Issue: 2 | Pages: e2557267

10.1001/jamanetworkopen.2025.57267 Get It

This cohort study evaluates the reduction in risk of high-grade serous carcinoma among women undergoing opportunistic bilateral salpingectomy in Canada.